Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Responding to Late Effects in Survivors of Childhood Cancer (RECOVER)

NCT06586502 is registered in ClinicalTrials.gov with Remziye Semerci as lead sponsor.

NCT NCT06586502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06586502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Responding to Late Effects in Survivors of Childhood Cancer (RECOVER)
Lead sponsor
Remziye Semerci
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 1, 2024
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

model of care, support, survivorship